Effectiveness of CoronaVac and BNT162b2 COVID-19 mass vaccination in Colombia: A population-based cohort study-Reference-Cited by-同舟云学术

Effectiveness of CoronaVac and BNT162b2 COVID-19 mass vaccination in Colombia: A population-based cohort study

Published:2022-08 Issue: Volume:12 Page:100296
ISSN:2667-193X
Container-title:The Lancet Regional Health - Americas
language:en
Short-container-title:The Lancet Regional Health - Americas

Author:

Paternina-Caicedo Angel^ORCID,Jit Mark,Alvis-Guzmán Nelson,Fernández Juan Carlos,Hernández José,Paz-Wilches Justo Jesus,Rojas-Suarez José,Dueñas-Castell Carmelo^ORCID,Alvis-Zakzuk Nelson J.,Smith Adrian D.,Hoz-Restrepo Fernando De La

Funder

Bill and Melinda Gates Foundation

Horizon 2020

National Institute for Health and Care Research

European Commission

Publisher

Elsevier BV

Reference33 articles.

1. An interactive web-based dashboard to track COVID-19 in real time;Dong;Lancet Infect Dis,2020

2. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine;Polack;N Engl J Med,2020

3. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021

4. Hitchings MDT, Ranzani OT, Torres MSS, et al. Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 gamma variant transmission in Manaus, Brazil: a test-negative case-control study. medRxiv 2021; 2021.04.07.21255081.

5. Ministerio de Salud de Chile;R,2021

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world effectiveness of the CoronaVac vaccine in a retrospective population-based cohort in four Colombian cities (2021-2022);International Journal of Infectious Diseases;2024-10

2. Factors influencing individual vaccine preferences for COVID‐19 in the Sunyani Municipality, Ghana: An observational study using discrete choice experiment analysis;Health Science Reports;2024-07

3. Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection;npj Vaccines;2024-02-20

4. Inactivated vaccine effectiveness against symptomatic COVID-19 in Fujian, China during the Omicron BA.2 outbreak;Frontiers in Public Health;2023-12-14

5. COVID-19 vaccine effectiveness against hospitalizations in Paraguay, May 2021—April 2022: A test-negative design;Vaccine;2023-10